Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.2100
+0.0300 (1.38%)
NASDAQ· Last Trade: Aug 3rd, 7:10 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors